Personas / Equipo Humano

Maria Teresa Peñarrubia Maria

Buscador de publicaciones

Publicaciones

  • Rubio-Valera M, Peñarrubia-María MT, Iglesias M, Martin Knapp, Pau McCrone, Roig M, Sabes R, Luciano JV, Mendive JM, Murrugara-Centurión AG, Alonso J and Serrano-Blanco A.

    Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study).

    EUROPEAN JOURNAL OF HEALTH ECONOMICS . 20(5): 703-713. Nº de citas: 3

    [doi:10.1007/s10198-019-01034-5]

  • Aznar I, Iglesias M, Rubio-Valera M, Peñarrubia-María MT, Mendive JM, Murrugarra-Centurión AG, Gil MM, González Suñer L, Peuters C and Serrano-Blanco A.

    Diagnostic accuracy and treatment approach to depression in primary care: predictive factors

    FAMILY PRACTICE . 36(1): 3-11. Nº de citas: 4

    [doi:10.1093/fampra/cmy098]

  • Aznar I, Pottegård A, Fernández A, Peñarrubia-María MT, Serrano-Blanco A, Sabés-Figuera R, Gil MM, Fajó-Pascual M, Moreno-Peral P and Rubio-Valera M.

    Effect of copayment policies on initial medication non-adherence according to income: a population-based study.

    BMJ QUALITY & SAFETY . 27(11): 878-891. Nº de citas: 23

    [doi:10.1136/bmjqs-2017-007416]

  • Iglesias M, Aznar I, Peñarrubia-María MT, Gil MM, Fernández-Vergel R, Alonso J, Serrano-Blanco A and Rubio-Valera M.

    Effectiveness of watchful waiting versus antidepressants for patients diagnosed of mild to moderate depression in primary care: A 12-month pragmatic clinical trial (INFAP study).

    EUROPEAN PSYCHIATRY . 53: 66-73. Nº de citas: 10

    [doi:10.1016/j.eurpsy.2018.06.005]

  • Aznar I, Iglesias M, Gil MM, Serrano-Blanco A, Fernández A, Peñarrubia-María MT, Sabés-Figuera R, Murrugarra-Centurión AG, March-Pujol M, Bolívar-Prados M and Rubio-Valera M.

    Impact of initial medication non-adherence to SSRIs on medical visits and sick leaves.

    JOURNAL OF AFFECTIVE DISORDERS . 226: 282-286. Nº de citas: 10

    [doi:10.1016/j.jad.2017.09.057]

  • Pérez A, Barceló A, Andrés L, Peñarrubia-María MT, Tuccillo R, Borraz-Estruch G, García-Campayo J, Feliu A and Luciano JV.

    Description and narrative review of well-established and promising psychological treatments for fibromyalgia

    Mindfulness & Compassion . 2(2): 112-129.

    [doi:10.1016/j.mincom.2017.10.002]

  • Feliu A, Reche-Camba E, Borràs X, Pérez A, Andrés L, Peñarrubia-María MT, Navarro-Gil M, García-Campayo J, Bellón JA and Luciano JV.

    Psychometric Properties of the Cognitive Emotion Regulation Questionnaire (CERQ) in Patients with Fibromyalgia Syndrome.

    FRONTIERS IN PSYCHOLOGY . 8: 2075-2075. Nº de citas: 33

    [doi:10.3389/fpsyg.2017.02075]

  • Iglesias M, Aznar I, Gil MM, Moreno-Peral P, Peñarrubia-María MT, Rubio-Valera M and Serrano-Blanco A.

    Comparing watchful waiting with antidepressants for the management of subclinical depression symptoms to mild-moderate depression in primary care: a systematic review.

    FAMILY PRACTICE . 34(6): 639-648. Nº de citas: 12

    [doi:10.1093/fampra/cmx054]

  • Aznar I, Fernández A, Gil MM, Sabés-Figuera R, Fajó-Pascual M, Peñarrubia-María MT, Serrano-Blanco A, Moreno-Peral P, Sánchez-Niubó A, March-Pujol M and Rubio-Valera M.

    Impact of initial medication non-adherence on use of healthcare services and sick leave: a longitudinal study in a large primary care cohort in Spain.

    BRITISH JOURNAL OF GENERAL PRACTICE . 67(662): 614-622. Nº de citas: 20

    [doi:10.3399/bjgp17X692129]

  • Luciano JV, Francesco D'Amico, Feliu A, McCracken LM, Aguado J, Peñarrubia-María MT, Martin Knapp, Serrano-Blanco A and García-Campayo J.

    Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study).

    JOURNAL OF PAIN . 18(7): 868-880. Nº de citas: 31

    [doi:10.1016/j.jpain.2017.03.001]